{
  "meta": {
    "title": "General_Anaesthetics",
    "url": "https://brainandscalpel.vercel.app/general-anaesthetics-ee180fef.html",
    "scrapedAt": "2025-11-29T18:33:29.716Z"
  },
  "questions": [
    {
      "id": 16902,
      "choices": [
        {
          "id": 67568,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The local anesthetic is required in the unionized form for penetrating the neuronal membrane.</span></span></span></p>"
        },
        {
          "id": 67569,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The local anesthetic approaches its receptor from the intraneuronal face of the Na+ channel.</span></span></span></p>"
        },
        {
          "id": 67570,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The local anesthetic binds to its receptor mainly when the Na+ channel is in the resting state.</span></span></span></p>"
        },
        {
          "id": 67571,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The local anesthetic combines with its receptor in the ionized cationic form.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is not true of local anesthetics?</span></span></span></p>",
      "unique_key": "Q3259979",
      "question_audio": null,
      "question_video": null,
      "map_id": 36261,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) The local anaesthetic binds to its receptor mainly when the Na+ channel is in the resting state</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Local anesthetics </strong>primarily bind to <strong>their receptor,</strong> the <strong>voltage-gated sodium channel,</strong> when it is in the <strong>activated (open) or inactivated</strong> state,<strong> not</strong> when it is in the<strong> resting state.</strong> This interaction <strong>blocks sodium influx</strong>, inhibiting the<strong> propagation of action potentials </strong>and achieving<strong> local anesthesia</strong>. The <strong>ionized form </strong>of the <strong>local anesthetic </strong>is essential for <strong>binding within the channel</strong>, but the<strong> unionized form </strong>is necessary for<strong> penetration </strong>through the <strong>neuronal lipid membrane </strong>to reach the <strong>intracellular site of action</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. The local anesthetic is required in the unionized form for penetrating the neuronal membrane:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>, as the <strong>unionized form </strong>is more <strong>lipophilic </strong>and can cross<strong> lipid membranes </strong>more easily.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. The local anesthetic approaches its receptor from the intraneuronal face of the Na+ channel:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>, once inside the <strong>neuron, </strong>the local anesthetic can access and<strong> bind to the inner portion of the sodium channel.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The local anesthetic combines with its receptor in the ionized cationic form:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> True,</strong> the <strong>ionized form </strong>of the drug is the <strong>active form </strong>that interacts with the <strong>sodium channel to block nerve conduction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the <strong>dual nature of local anesthetics&#39; </strong>interaction with <strong>sodium channels is crucial</strong>. They must be capable of <strong>both lipophilic and hydrophilic behavior </strong>to effectively penetrate <strong>nerve cells and exert their blocking action</strong>, highlighting the importance of their<strong> molecular structure in clinical efficacy</strong>.</span></span></span></p>",
      "correct_choice_id": 67570,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16891,
      "choices": [
        {
          "id": 67524,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lignocaine concentration is initially higher in relatively well perfused tissues such as brain and heart</span></span></span></p>"
        },
        {
          "id": 67525,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histamine receptors in brain and heart get suddenly activated in circulatory failure</span></span></span></p>"
        },
        {
          "id": 67526,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is a sudden outburst of release of adrenaline, noradrenaline and dopamine in brain and heart</span></span></span></p>"
        },
        {
          "id": 67527,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lignocaine is converted to a toxic metabolite due to its longer stay in the liver</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac or central nervous system toxicity may result when standard lignocaine doses are administered to patients with circulatory failure. This may be due to the following reason?</span></span></span></p>",
      "unique_key": "Q1121160",
      "question_audio": null,
      "question_video": null,
      "map_id": 36260,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Lignocaine concentration is initially higher in relatively well perfused tissues such as brain and heart</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lignocaine </strong>is <strong>widely used </strong>as a <strong>local anesthetic and antiarrhythmic agent</strong>. In the setting of <strong>circulatory failure</strong>, the redistribution of <strong>blood flow to vital organs like the brain and heart </strong>can lead to disproportionately<strong> higher concentrations of lignocaine </strong>in these tissues. Because<strong> lignocaine acts on sodium channels </strong>which are abundant in <strong>both the central nervous system and the heart, increased </strong>concentrations can lead to <strong>toxicity </strong>manifesting as <strong>seizures, confusion, and cardiovascular instability. </strong>This increased risk is particularly pronounced in conditions where blood flow dynamics are altered.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Histamine receptors in brain and heart get suddenly activated in circulatory failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> incorrect </strong>as histamine receptor activation is<strong> not directly </strong>related to<strong> lignocaine&#39;s mechanism </strong>of action nor its distribution.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. There is a sudden outburst of release of adrenaline, noradrenaline, and dopamine in brain and heart:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>stress hormones </strong>do increase in <strong>circulatory failure</strong>, this <strong>does not </strong>directly affect the<strong> pharmacokinetics or local concentrations of lignocaine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lignocaine is converted to a toxic metabolite due to its longer stay in the liver:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong>, as <strong>lignocaine </strong>is indeed <strong>metabolized in the liver</strong>, but its metabolites are generally<strong> not significantly toxic</strong>, and the primary concern in<strong> circulatory failure</strong> is not hepatic metabolism but <strong>altered tissue distribution.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In circulatory failure, increased lignocaine concentrations in well-perfused organs such as the brain and heart can lead to toxicity, highlighting the need for cautious dosing and monitoring in patients with compromised circulation.</span></strong></span></span></p>",
      "correct_choice_id": 67524,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16887,
      "choices": [
        {
          "id": 67508,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It blocks active sodium channels with more affinity than resting sodium channels</span></span></span></p>"
        },
        {
          "id": 67509,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can cause cardiotoxicity</span></span></span></p>"
        },
        {
          "id": 67510,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is given orally for treatment of cardiac arrhythmias</span></span></span></p>"
        },
        {
          "id": 67511,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline increases the duration of action of lignocaine when used for infiltration anaesthesia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following statements about lignocaine are true except:</span></span></span></p>",
      "unique_key": "Q4526414",
      "question_audio": null,
      "question_video": null,
      "map_id": 36262,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) It is given orally for treatment of cardiac arrhythmias</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lignocaine (lidocaine) </strong>is primarily used as a<strong> local anesthetic and antiarrhythmic agent</strong>. However, due to its <strong>high first-pass metabolism in the liver</strong>, it is <strong>not effective </strong>when given <strong>orally </strong>for the treatment of <strong>cardiac arrhythmias</strong>. It must be<strong> administered intravenously</strong> to<strong> bypass hepatic metabolism </strong>and be effective in<strong> controlling cardiac arrhythmias</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It blocks active sodium channels with more affinity than resting sodium channels:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>,<strong> lignocaine </strong>preferentially binds to and<strong> blocks sodium channels </strong>in their <strong>active or open </strong>state, which contributes to its <strong>effectiveness as a local anesthetic.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It can cause cardiotoxicity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True, </strong>at <strong>high blood concentrations,</strong> lignocaine can have <strong>toxic effects on the heart, </strong>including <strong>arrhythmias and cardiac arrest.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Adrenaline increases the duration of action of lignocaine when used for infiltration anesthesia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>, <strong>adrenaline (epinephrine) </strong>is added to <strong>lignocaine </strong>in infiltration anesthesia to cause<strong> vasoconstriction, </strong>which <strong>reduces blood flow </strong>and slows the <strong>absorption of lignocaine, </strong>thereby <strong>prolonging its duration of action and reducing systemic toxicity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understand that<strong> lignocaine is ineffective orally for cardiac arrhythmias </strong>due to its <strong>high first-pass metabolism</strong>, necessitating <strong>intravenous administration for therapeutic effectiveness.</strong></span></span></span></p>",
      "correct_choice_id": 67510,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16888,
      "choices": [
        {
          "id": 67512,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibiting nicotinic receptors at myoneural junction</span></span></span></p>"
        },
        {
          "id": 67513,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibiting nicotinic receptors at autonomic ganglion</span></span></span></p>"
        },
        {
          "id": 67514,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Producing depolarizing block</span></span></span></p>"
        },
        {
          "id": 67515,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">By inhibiting reuptake of acetylcholine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">d-Tubocurarine acts by?</span></span></span></p>",
      "unique_key": "Q7240142",
      "question_audio": null,
      "question_video": null,
      "map_id": 36259,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Inhibiting nicotinic receptors at myoneural junction</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>d-Tubocurarine </strong>is a <strong>non-depolarizing neuromuscular blocking agent</strong> that competes with<strong> acetylcholine </strong>for binding to the <strong>nicotinic</strong> <strong>receptors at the neuromuscular junction</strong>. By binding to these receptors, <strong>d-Tubocurarine blocks the action of acetylcholine, </strong>which normally <strong>triggers muscle contraction.</strong> This results in <strong>skeletal muscle relaxation and paralysis,</strong> making it <strong>useful during surgical</strong> <strong>procedures</strong> to maintain muscle relaxation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Inhibiting nicotinic receptors at autonomic ganglion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, </strong>as <strong>d-Tubocurarine </strong>specifically targets <strong>nicotinic receptors at the neuromuscular junction</strong>, not autonomic ganglia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Producing depolarizing block:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, d-Tubocurarine is a non-depolarizing blocker</strong>, unlike <strong>succinylcholine, </strong>which produces a <strong>depolarizing block.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. By inhibiting reuptake of acetylcholine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong>, <strong>d-Tubocurarine does not </strong>affect the <strong>reuptake of acetylcholine; </strong>it competes with<strong> acetylcholine at the receptor level</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognize <strong>d-Tubocurarine </strong>as a<strong> non-depolarizing neuromuscular blocker </strong>that inhibits <strong>nicotinic receptors </strong>at the <strong>myoneural junction</strong>, used primarily to induce <strong>muscle relaxation during surgery.</strong></span></span></span></span></span></span></p>",
      "correct_choice_id": 67512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}